Observational studyJournal of global health2026
Global and regional burden of chikungunya from 2004 to 2024: a worldwide observational study.
Observational study in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chikungunya Virus Mosquito Vectors: A Global Review of Field Surveillance and Laboratory Vector Competence (2020-2026).Insects · 2026Review
- Seroprevalence of chikungunya virus in Colombo, Sri Lanka before the 2025 outbreak and implications for population susceptibility.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chikungunya has emerged as a growing global health threat with a new sharp rise in outbreaks across 119 countries. However, its transmission patterns remain poorly characterised. We aimed to describe the global burden and spatiotemporal trends of chikungunya, and identify country-level environmental and socioeconomic factors associated with local transmission. Methods: We compiled annual country-level autochthonous chikungunya cases from 2004 to 2024, using data from regional surveillance systems and peer-reviewed sources. We calculated the incidence rates using the number of new cases and the population. We employed a generalised additive model (GAM) to flexibly model nonlinear associations between chikungunya incidence and environmental and socioeconomic factors. We performed subgroup analyses across the six WHO regions and conducted multiple sensitivity analyses addressing data structure, variable selection, and alternative model specifications to assess robustness. Results: Between 2004 and 2024, the global incidence of chikungunya from autochthonous cases rose from 0.28 to 11.13 per 100 000. In 2024, the Americas bore the heaviest burden (43.9 per 100 000; 431 305 cases), followed by South-East Asia (14.3 per 100 000; 258 854 cases), while Africa, Europe, and the Western Pacific reported few cases. Local outbreaks occurred recurrently in several countries across the Americas, South-East Asia, and Western Pacific, but remained sporadic in temperate regions. Using a GAM, we identified significant nonlinear effects of temperature, urbanisation, and GDP per capita on incidence: incidence rose sharply above 17°C; urban population percentage demonstrated a complex, nonlinear relationship; and GDP showed an inverse association at low to moderate levels. After adjusting for environmental and socioeconomic factors, the temporal trend of incidence generally declined. We identified notable heterogeneity across regions, while our results otherwise remained broadly consistent across the sensitivity analyses. Conclusions: Chikungunya burden has expanded globally, shaped by environmental and socioeconomic factors. Strengthened surveillance, integration of climate information into preparedness efforts, and improvements in socioeconomic conditions are needed to reduce disparities and support more effective prevention of future outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.